Hot Investor Mandate 1: France-Based VC Initially Invests Up to $15M in Eary-Stage Therapeutics and Medical Device Companies

29 Mar

A venture capital firm based in Paris, France invests in early stage life science companies and seeks to be the first institutional investor in a company. The firm has raised numerous funds to date and currently has approximately €1.4 billion AUM. The firm is currently investing from its recent fund of €300M. The firm makes seed and venture investments, oftentimes investing in a company’s seed round and later leading the Company’s A round. The firm can allocate €1-15M initially and up to € 30 M over the life of the investment.

The firm is currently looking for biotech therapeutics and medical devices and tends to steer away from service companies. For therapeutics, the firm is agnostic in terms of subsector and invests in small molecule, biologics, cell and gene therapy, etc. The firm is also indication agnostic, but currently most interested in oncology (especially CAR-T assets), immunology/inflammation, CNS/neurology (with a particular interest in rare neuro conditions). The firm will consider products as early as 24-months from IND through to Phase III. For medical devices, the firm seeks paradigm-shifting technologies that can reach a human proof-of-concept stage in a relatively short period of time, and prefers PMA regulatory pathways although is open to other regulatory pathways as well.

The firm prefers to lead or co-lead an investment and generally requires a board seat in its portfolio companies. The firm seeks outstanding entrepreneurial management teams.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: